Stability of epinephrine at standard concentrations

Roxane R Carr1, Diane Decarie2, Mary H H Ensom3

  • 1, BSc(Pharm), ACPR, PharmD, FCSHP, BCPS, is Clinical Coordinator in the Department of Pharmacy, Children's and Women's Health Centre of British Columbia, and Assistant Professor, part-time, with the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.

Insights

Epinephrine solutions in dextrose are stable for 30 days at standard concentrations, whether refrigerated or at room temperature. This stability supports premixing for improved pediatric care, though further clinical studies are recommended.

Area of Science:

  • Pharmacology
  • Pharmaceutical Science
  • Pediatric Critical Care

Background:

  • Standardized medication concentrations are crucial for minimizing errors in pediatric continuous infusions.
  • Premixing epinephrine, a key treatment for pediatric septic shock, can enhance safety, timeliness, and cost-effectiveness.
  • Limited data exists on the stability of epinephrine at standard concentrations used in pediatric care.

Purpose of the Study:

  • To assess the stability of epinephrine in 5% dextrose in water at standard concentrations.
  • To determine the extended expiration date for epinephrine infusion bags stored at 4°C and 25°C for up to 30 days.

Main Methods:

  • Epinephrine solutions at three standard concentrations (25, 50, 100 μg/mL) were prepared in 5% dextrose in water.
  • Infusion bags were stored at 4°C and 25°C, with physical characteristics monitored daily and then every 1-5 days up to 30 days.
  • High-performance liquid chromatography was used to analyze epinephrine concentration, with stability defined as ≥90% of initial concentration.

Main Results:

  • No significant changes in pH, color, or precipitate were observed in any epinephrine solutions over 30 days at either temperature.
  • All epinephrine formulations retained over 95% of their initial concentration at day 30.
  • The 95% confidence interval indicated that at least 93% of the initial epinephrine concentration remained on day 30.

Conclusions:

  • Epinephrine preparations in 5% dextrose in water are stable for up to 30 days, irrespective of refrigeration.
  • The demonstrated stability supports the potential for premixed epinephrine in standard concentrations for pediatric use.
  • Future clinical research is recommended to evaluate the pharmacokinetics and pharmacodynamics of these stable epinephrine formulations.
Abstract

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.6K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.3K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Steady State Concentration01:05

Steady State Concentration

A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.
Most drugs are administered in repeated doses at fixed intervals or through continuous...
5.9K